Anika Therapeutics, Inc.
ANIKNasdaq
$15.25
↓ -3.6%Jul 17 close · end-of-day
Price
1Y↑ +36.3%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$206.3M
Enterprise Value
$139.6M
P/E
—
P/S
1.8
P/B
1.5
EV/EBITDA
—
PEG
—
FCF Yield
0.5%
Dividend Yield
—
Revenue (TTM)
$116.3M
Net Income (TTM)
-$11.1M
Free Cash Flow (TTM)
$1.0M
Gross Margin
58.6%
Operating Margin
-10.5%
Net Margin
-9.5%
ROE
-8.3%
ROIC
-14.4%
Debt / Equity
—
Net Cash
$66.8M
Return 1Y
+35.7%
Company profile
Anika Therapeutics, Inc. creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform.
- CEO
- Cheryl R. Blanchard
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 300
- Headquarters
- Massachusetts
- Website
- anikatherapeutics.com
Management & directors
- Griffin Stephen D.President and CEO
- Colleran DavidEVP, General Counsel, Corp Sec
- Mcleod IanSVP, CAO & Treasurer
Roles derived from SEC Form 4 filings.
Earnings
ANIK Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$29.6M↑ +13.2%
Diluted EPS-$0.37↑ +8.8%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $130.5M | $147.8M | $113.8M | $120.8M | $119.9M | $112.8M |
| Gross profit | $69.0M | $82.9M | $73.2M | $82.5M | $76.0M | $63.8M |
| Operating income | -$28.3M | $2.6M | $3.7M | $844,000.00 | -$5.1M | -$11.1M |
| Net income | -$24.0M | $4.1M | -$14.9M | -$82.7M | -$56.4M | -$10.9M |
| Diluted EPS | -$1.69 | $0.28 | -$1.02 | -$5.64 | -$3.83 | -$0.76 |
| Operating cash flow | $13.1M | $8.4M | $4.4M | -$1.8M | $5.4M | $11.2M |
| Free cash flow | $11.4M | $3.3M | -$3.1M | -$7.2M | -$2.3M | $4.4M |
| Gross margin | 52.9% | 56.1% | 64.3% | 68.3% | 63.4% | 56.6% |
| Operating margin | -21.7% | 1.8% | 3.2% | 0.7% | -4.3% | -9.8% |
| Net margin | -18.4% | 2.8% | -13.1% | -68.4% | -47.0% | -9.6% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $30.7M | $29.6M | $30.6M | $26.2M | $28.2M | $27.8M | $30.6M | $29.6M |
| Gross profit | $20.5M | $19.4M | $17.1M | $14.7M | $14.4M | $15.6M | $19.2M | $19.0M |
| Operating income | -$1.8M | -$81,000.00 | -$705,000.00 | -$4.3M | -$4.2M | -$3.2M | $646,000.00 | -$5.5M |
| Net income | -$88,000.00 | -$29.9M | -$21.9M | -$4.9M | -$4.0M | -$2.3M | $292,000.00 | -$5.1M |
| Diluted EPS | $0.00 | -$2.03 | -$1.49 | -$0.34 | -$0.28 | -$0.16 | $0.02 | -$0.37 |
| Operating cash flow | -$1.1M | $5.0M | $1.6M | -$130,000.00 | -$189,000.00 | $6.9M | $4.6M | -$4.8M |
| Free cash flow | -$4.5M | $3.8M | $275,000.00 | -$3.0M | -$1.7M | $5.0M | $4.0M | -$6.3M |
| Gross margin | 66.7% | 65.7% | 56.0% | 56.1% | 50.9% | 56.0% | 62.6% | 64.2% |
| Operating margin | -5.9% | -0.3% | -2.3% | -16.4% | -14.8% | -11.6% | 2.1% | -18.5% |
| Net margin | -0.3% | -101.2% | -71.4% | -18.6% | -14.1% | -8.4% | 1.0% | -17.1% |
Company news
Jul 15, 2026
Jun 5, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-18 | HENNEMAN JOHN B III | Award | 10,402 | $0.00 | $0.00 | filing |
| 2026-06-18 | Fishetti Gary P | Award | 10,402 | $0.00 | $0.00 | filing |
| 2026-06-18 | Richard Stephen | Award | 10,402 | $0.00 | $0.00 | filing |
| 2026-06-18 | Capper Joseph H | Award | 10,402 | $0.00 | $0.00 | filing |
| 2026-06-18 | CONLEY SHERYL L | Award | 10,402 | $0.00 | $0.00 | filing |
| 2026-06-03 | Griffin Stephen D.· President and CEO | Tax withholding | 3,769 | $14.41 | $54,311.29 | filing |
| 2026-06-03 | Griffin Stephen D.· President and CEO | Option exercise | 12,840 | — | — | filing |
| 2026-05-01 | HENNEMAN JOHN B III | Buy | 5,000 | $14.66 | $73,319.50 | filing |
| 2026-04-30 | Griffin Stephen D.· President and CEO | Buy | 12,200 | $12.29 | $149,880.66 | filing |
| 2026-03-15 | Blanchard Cheryl R | Tax withholding | 12,104 | $14.20 | $171,876.80 | filing |
| 2026-03-15 | Colleran David· EVP, General Counsel, Corp Sec | Tax withholding | 1,893 | $14.20 | $26,880.60 | filing |
| 2026-03-15 | McLeod Ian· SVP, CAO & Treasurer | Tax withholding | 781 | $14.20 | $11,090.20 | filing |
| 2026-03-15 | McLeod Ian· SVP, CAO & Treasurer | Option exercise | 2,658 | — | — | filing |
| 2026-03-15 | Colleran David· EVP, General Counsel, Corp Sec | Option exercise | 6,449 | — | — | filing |
| 2026-03-15 | Blanchard Cheryl R | Option exercise | 25,131 | — | — | filing |
| 2026-03-14 | Blanchard Cheryl R | Tax withholding | 14,728 | $14.20 | $209,137.60 | filing |
| 2026-03-14 | Griffin Stephen D.· President and CEO | Tax withholding | 5,944 | $14.20 | $84,404.80 | filing |
| 2026-03-14 | Colleran David· EVP, General Counsel, Corp Sec | Tax withholding | 4,168 | $14.20 | $59,185.60 | filing |
| 2026-03-14 | McLeod Ian· SVP, CAO & Treasurer | Tax withholding | 1,449 | $14.20 | $20,575.80 | filing |
| 2026-03-14 | Blanchard Cheryl R | Award | 24,520 | $0.00 | $0.00 | filing |
| 2026-03-14 | Colleran David· EVP, General Counsel, Corp Sec | Award | 4,694 | $0.00 | $0.00 | filing |
| 2026-03-14 | McLeod Ian· SVP, CAO & Treasurer | Award | 1,161 | $0.00 | $0.00 | filing |
| 2026-03-14 | Griffin Stephen D.· President and CEO | Award | 6,412 | $0.00 | $0.00 | filing |
| 2026-03-14 | Blanchard Cheryl R | Option exercise | 24,519 | — | — | filing |
| 2026-03-14 | Griffin Stephen D.· President and CEO | Option exercise | 12,824 | — | — | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.